Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus

Rheumatology International

Volumn 33, Issue 1, 2013, Pages 259-263

  Závada, Jakub ^a   Nytrova P ^b   Wandinger, K P ^c   Jarius, S ^d   Svobodova R ^a   Probst, C ^c   Peterova V ^b   Tegzova D ^a   Pavelka, K ^a   Vencovsky J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Institute of Experimental Immunology   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anti aquaporin 4 antibody; Aquaporin4; Longitudinally extensive transverse myelitis; Neuromyelitis optica; Neuropsychiatric systemic lupus erythematosus; Optic neuritis

Indexed keywords

AQUAPORIN 4 ANTIBODY; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE;

ADULT; ANXIETY DISORDER; ARTICLE; ASEPTIC MENINGITIS; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONFUSION; CRANIAL NEUROPATHY; DEMYELINATING DISEASE; FEMALE; HEADACHE; HUMAN; IMMUNOFLUORESCENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MONONEUROPATHY; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; POLYNEUROPATHY; PRIORITY JOURNAL; PSYCHOSIS; SEIZURE; SEROPREVALENCE; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

AQUAPORIN 4; BIOLOGICAL MARKERS; COMORBIDITY; CZECH REPUBLIC; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN G; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MYELITIS, TRANSVERSE; PREVALENCE; RECOMBINANT PROTEINS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84872295568     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2176-4     Document Type: Article

References (20)

1. Bertsias GK, Ioannidis JP, Aringer M et al (2010) EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 69(12):2074-2082
2. Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ (2000) Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59:120-124
3. Lin YC, Wang AG, Yen MY (2009) Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review. Acta Ophthalmol 87(2):204-210
4. Feinglass EJ, Arnett FC, Dorsch CA, Zizic TM, Stevens MB (1976) Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 55(4):323-339
5. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106-2112
6. Hinson SR, McKeon A, Lennon VA (2010) Neurological autoimmunity targeting aquaporin-4. Neuroscience 168(4):1009-1018
7. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zéphir H, Moder K, Weinshenker BG (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65(1):78-83
8. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599-608
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
10. Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W et al (2010) Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 291:52-56
11. Wandinger KP, Stangel M, Witte T, Venables P, Charles P, Jarius S, Wildemann B, Probst C, Iking-Konert C, Schneider M (2010) Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum 62(4):1198-1200
12. Jarius S, Frederikson J, Waters P, Paul F, Akman-Demir G, Marignier R, Franciotta D, Ruprecht K, Kuenz B, Rommer P, Kristoferitsch W, Wildemann B, Vincent A (2010) Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 298(1-2):158-162
13. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485-1489
14. Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T et al (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131:3072-3080
15. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59(3):566-569
16. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC (2010) Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133(Pt 2):349-361
17. Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S (2009) Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun 386(4):623-627
18. Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131(Pt 11):3072-3080
19. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y (2007) Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130(Pt 5):1235-1243
20. Birnbaum J, Kerr D (2007) Devic's syndrome in a woman with systemic lupus erythematosus: diagnostic and therapeutic implications of testing for the neuromyelitis optica IgG autoantibody. Arthritis Rheum 57(2):347-351